Cerenome, Inc expected to post a loss of 96 cents a share - Earnings Preview

What happened

Cerenome, Inc is expected to report a 34.1% revenue decrease to $920.33 thousand for the quarter ending September 30, 2026, down from $1.4 million a year earlier, according to three analysts. Analysts expect a loss of 96 cents per share when results are reported October 28.

Confirmed

Global impact / market context

A smaller revenue base means less cash coming in to cover fixed costs, so a loss of 96 cents per share signals the company may need to cut spending or raise outside money. Repeated misses in recent quarters suggest analysts have struggled to predict its results.

Analyst inference

Analysts rate the shares a buy, with four buy ratings and none hold or sell, and a median 12-month price target of $28.00 versus a last close of $1.64. The estimate was unchanged over three months, so expectations are stable going into the report.

Analyst inference

What to watch

1. Watch whether actual revenue lands near the $920.33 thousand estimate and whether the reported loss per share comes close to the expected 96 cents when results are released October 28. Confirmed
2. The company missed earnings estimates in three of the last four quarters, so another miss could pressure the shares, while a beat could support the buy ratings and the high price target. Analyst inference
3. Investors could compare the new loss figure with prior quarters to judge whether losses are narrowing toward profitability, since that direction matters more than whether one estimate was beaten. Proposed

Evidence

• Original source link unavailable